Belgian device outfit attracts $5.4M Series A for ophthalmic implant development

Fledgling Belgian medical device company iSTAR Medical SA has raised nearly $5.4 million in Series A financing designed to back further clinical studies of its ophthalmic implant for glaucoma. The company said the money will also support efforts to prepare for U.S. regulatory submission and clearance, as well as other R&D programs. Capricorn Health-Tech Fund NV co-led the round with Société Régionale d'Investissement deWallonie (SRIW). Financière Spin-off Luxembourgeoise (INVESTSUD Group) and Namur Invest-Preface also participated. The startup is the first spinout of Healionics, a Seattle-based company founded in 2007 to advance a precision-engineered three-dimensional biomaterial scaffold designed to heal around a medical device and promote acceptance in the body. Item